Structures by: Begum N. S.
Total: 51
4-Amino-6-(piperidin-1-yl)pyrimidine-5-carbonitrile
C10H13N5
IUCrData (2020) 5, 3
a=10.7335(9)Å b=12.4005(10)Å c=7.9206(6)Å
α=90° β=93.654(4)° γ=90°
2-[1-(4-<i>tert</i>-Butylphenyl)-4,5-diphenyl-1<i>H</i>-imidazol-2-yl]-4,6-dichlorophenol
C31H26Cl2N2O
IUCrData (2020) 5, 7 x200870
a=9.8084(10)Å b=11.6806(11)Å c=12.0754(13)Å
α=77.474(6)° β=85.686(6)° γ=80.742(6)°
4-Chloro-2-[1-(4-ethylphenyl)-4,5-diphenyl-1<i>H</i>-imidazol-2-yl]phenol
C29H23ClN2O
IUCrData (2020) 5, 1 x191690
a=9.0627(6)Å b=10.7595(8)Å c=24.4636(19)Å
α=90° β=100.599(3)° γ=90°
2-[4,5-Bis(4-bromophenyl)-1-(4-<i>tert</i>-butylphenyl)-1<i>H</i>-imidazol-2-yl]-4,6-dichlorophenol
C31H24Br2Cl2N2O
IUCrData (2019) 4, 12 x191672
a=17.7619(5)Å b=12.7435(4)Å c=28.2194(8)Å
α=90° β=102.478(2)° γ=90°
Ethyl 4-(4-chloro-3-fluorophenyl)-6-methyl-2-sulfanylidene-1,2,3,4-tetrahydropyrimidine-5-carboxylate
C14H14ClFN2O2S
IUCrData (2019) 4, 7 x190960
a=7.2599(5)Å b=9.4979(7)Å c=11.9596(8)Å
α=106.149(2)° β=90.236(2)° γ=108.939(2)°
(2-Hydroxyphenyl)(4,2':4',4''-terpyridin-6'-yl)methanone
C22H15N3O2
IUCrData (2020) 5, 7 x200857
a=7.2994(2)Å b=9.6105(3)Å c=23.9296(8)Å
α=90° β=90° γ=90°
Ethyl 4-(2,5-dimethylphenyl)-6-methyl-2-sulfanylidene-1,2,3,4-tetrahydropyrimidine-5-carboxylate
C16H20N2O2S
IUCrData (2017) 2, 10 x171440
a=14.4124(7)Å b=14.9172(6)Å c=15.1412(6)Å
α=90° β=100.3770(10)° γ=90°
C11H9FN2O3
C11H9FN2O3
New Journal of Chemistry (2020) 44, 17 7001-7006
a=10.8098(10)Å b=3.9789(4)Å c=24.250(2)Å
α=90° β=92.803(9)° γ=90°
Ethyl 2-cyano-3-[(1-ethoxyethylidene)amino]-5-(3-methoxyphenyl)-7-methyl-5<i>H</i>-1,3-thiazolo[3,2-<i>a</i>]pyrimidine-6-carboxylate
C22H24N4O4S
Acta Crystallographica Section E (2015) 71, 4 o256-o257
a=14.371(3)Å b=13.368(3)Å c=22.771(6)Å
α=90.000(5)° β=99.325(5)° γ=90.00(5)°
Ethyl 6-(2-fluorophenyl)-4-hydroxy-2-sulfanylidene-4-trifluoromethyl- 1,3-diazinane-5-carboxylate
C14H14F4N2O3S
Acta Crystallographica Section E (2015) 71, 5 o268-o269
a=10.937(3)Å b=9.934(3)Å c=14.629(4)Å
α=90.00° β=108.239(5)° γ=90.00°
2-(4-Chloro-3-fluorophenyl)-1<i>H</i>-benzimidazole
C13H8ClFN2
Acta Crystallographica Section E (2015) 71, 6 o387-o388
a=9.2302(4)Å b=9.8500(4)Å c=23.1347(9)Å
α=90.00° β=90.00° γ=90.00°
2-(3,4-Difluorophenyl)-1<i>H</i>-benzimidazole
C13H8F2N2
Acta Crystallographica Section E (2013) 69, 11 o1689
a=8.7195(17)Å b=9.9454(19)Å c=23.389(4)Å
α=90.00° β=90.00° γ=90.00°
4-Azidomethyl-6-isopropyl-2<i>H</i>-chromen-2-one
C13H13N3O2
Acta Crystallographica Section E (2015) 71, 4 o227-o228
a=6.895(2)Å b=7.862(2)Å c=11.592(4)Å
α=72.218(6)° β=79.662(5)° γ=82.430(6)°
6-Chloro-3-[(dimethylamino)methylidene]thiochroman-4-one
C12H12ClNOS
Acta crystallographica. Section E, Structure reports online (2013) 69, Pt 10 o1521
a=11.0031(3)Å b=12.5937(3)Å c=13.0787(3)Å
α=90.00° β=100.255(2)° γ=90.00°
Methyl 5-(4-acetoxyphenyl)-2-(2-bromobenzylidine)-7-methyl-3-oxo-2,3-dihydro-5<i>H</i>-1,3-thiazolo[3,2-<i>a</i>]pyrimidine-6-carboxylate
C24H19BrN2O5S
Acta crystallographica. Section E, Structure reports online (2013) 69, Pt 8 o1262
a=7.6018(5)Å b=11.9648(7)Å c=14.0877(9)Å
α=106.4250(10)° β=104.700(2)° γ=106.2960(10)°
4-Bromomethyl-6-<i>tert</i>-butyl-2<i>H</i>-chromen-2-one
C14H15BrO2
Acta crystallographica. Section E, Structure reports online (2013) 69, Pt 7 o1056
a=10.3311(19)Å b=16.830(3)Å c=7.3374(14)Å
α=90.00° β=97.518(3)° γ=90.00°
2-[4-(Trifluoromethoxy)phenyl]-1<i>H</i>-benzimidazole
C14H9F3N2O
Acta crystallographica. Section E, Structure reports online (2013) 69, Pt 2 o264
a=14.476(6)Å b=9.312(4)Å c=9.835(4)Å
α=90.00° β=108.192(8)° γ=90.00°
Ethyl 5-[3-(dimethylamino)acryloyl]-2-{[(dimethylamino)methylidene]amino}-4-methyl-thiophene-3-carboxylate
C16H23N3O3S
Acta crystallographica. Section E, Crystallographic communications (2015) 71, Pt 12 o908-9
a=7.6954(5)Å b=8.1799(5)Å c=13.9626(9)Å
α=95.928(2)° β=103.685(2)° γ=90.137(2)°
4-(2-Fluorophenyl)-6-methyl-2-sulfanylidene-1,2,3,4-tetrahydropyrimidine-5-carboxylate
C13H13FN2O2S
Acta crystallographica. Section E, Crystallographic communications (2015) 71, Pt 11 o838-9
a=13.3298(15)Å b=7.1509(8)Å c=14.5703(17)Å
α=90.00° β=109.854(4)° γ=90.00°
2-Acetyl-5-(3,4-dimethoxyphenyl)-6-ethoxycarbonyl-3,7-dimethyl-5<i>H</i>-thiazolo[3,2-<i>a</i>]pyrimidin-8-ium chloride
C21H25N2O5S,Cl
Acta crystallographica. Section E, Crystallographic communications (2015) 71, Pt 10 o764-5
a=9.9000(6)Å b=11.8563(7)Å c=19.0377(11)Å
α=80.827(2)° β=83.999(2)° γ=86.071(2)°
Ethyl 5-acetyl-2-{[(dimethylamino)methylidene]amino}-4-methylthiophene-3-carboxylate
C13H18N2O3S
Acta crystallographica. Section E, Crystallographic communications (2015) 71, Pt 10 o762-3
a=12.218(3)Å b=7.332(2)Å c=30.923(8)Å
α=90.00° β=90.00° γ=90.00°
Ethyl 4-(2-fluorophenyl)-6-methyl-2-sulfanylidene-1,2,3,4-tetrahydropyrimidine-5-carboxylate
C14H15FN2O2S
Acta crystallographica. Section E, Crystallographic communications (2015) 71, Pt 10 o699-700
a=8.9298(6)Å b=11.5870(8)Å c=15.7459(11)Å
α=100.940(2)° β=104.804(2)° γ=98.153(2)°
Ethyl 2-acetyl-3,7-dimethyl-5-(thiophen-2-yl)-5<i>H</i>-thiazolo[3,2-<i>a</i>]pyrimidine-6-carboxylate
C17H18N2O3S2
Acta crystallographica. Section E, Crystallographic communications (2015) 71, Pt 7 o477-8
a=7.8835(10)Å b=14.4041(19)Å c=15.231(2)Å
α=90.00° β=94.940(4)° γ=90.00°
2-(2-Fluorobenzylidene)-5-(4-fluorophenyl)-7-methyl-3-oxo-2,3-dihydro-5<i>H</i>-1,3-thiazolo[3,2-<i>a</i>]pyrimidine-6-carboxylate
C23H18F2N2O3S
Acta crystallographica. Section E, Structure reports online (2014) 70, Pt 12 o1270-1
a=24.746(5)Å b=9.6879(17)Å c=16.757(3)Å
α=90.00° β=92.022(5)° γ=90.00°
1-(2,4-Dimethylphenyl)-2-(4-trimethylsilyl-1<i>H</i>-1,2,3-triazol-1-yl)ethanone
C15H21N3OSi
Acta crystallographica. Section E, Structure reports online (2014) 70, Pt 12 o1253
a=5.961(3)Å b=13.374(7)Å c=20.349(11)Å
α=79.034(10)° β=84.831(10)° γ=85.123(10)°
2-Acetyl-5-(3-methoxy-phenyl)-3,7-dimethyl-5<i>H</i>-thiazolo[3,2-<i>a</i>]pyrimidine-6-carboxylic acid ethyl ester
C20H22N2O4S
Acta crystallographica. Section E, Structure reports online (2014) 70, Pt 11 o1204
a=8.281(3)Å b=9.680(4)Å c=12.821(5)Å
α=76.423(10)° β=86.308(10)° γ=74.641(11)°
Ethyl 5-(3-fluorophenyl)-2-[(4-fluorophenyl)methylidene]-7-methyl-3-oxo-2<i>H</i>,3<i>H</i>,5<i>H</i>-[1,3]thiazolo[3,2-<i>a</i>]pyrimidine-6-carboxylate
C23H18F2N2O3S
Acta crystallographica. Section E, Structure reports online (2014) 70, Pt 11 o1187-8
a=9.4358(5)Å b=10.7862(6)Å c=20.2246(11)Å
α=90.00° β=92.1590(10)° γ=90.00°
2-[4-(Trifluoromethyl)phenyl]-1<i>H</i>-benzimidazole
C14H9F3N2
Acta crystallographica. Section E, Structure reports online (2014) 70, Pt 7 o760
a=9.2292(9)Å b=9.8117(10)Å c=25.347(2)Å
α=90.00° β=90.00° γ=90.00°
Methyl 4-(4-hydroxyphenyl)-6-methyl-2-sulfanylidene-1,2,3,4-tetrahydropyrimidine-5-carboxylate
C13H14N2O3S
Acta crystallographica. Section E, Structure reports online (2014) 70, Pt 3 o306
a=7.3016(12)Å b=7.6855(13)Å c=11.4706(19)Å
α=88.337(3)° β=84.870(3)° γ=89.937(3)°
C9H10O3
C9H10O3
Acta Crystallographica Section C (1992) 48, 6 1076-1078
a=8.2480(10)Å b=5.145(2)Å c=19.724(2)Å
α=90° β=90.670(10)° γ=90°
C21H22N2O4S
C21H22N2O4S
Acta Crystallographica Section C (1992) 48, 5 902-905
a=9.7990(10)Å b=11.8530(10)Å c=17.316(2)Å
α=90° β=90° γ=90°
C11H20Si1,Cl2Pd1
C11H20Si1,Cl2Pd1
Acta Crystallographica Section C (1994) 50, 8 1227-1231
a=12.5360(10)Å b=12.867(2)Å c=17.759(2)Å
α=90.° β=93.010(10)° γ=90.°
Tetrahydrocurcumin
C21H24O6
Acta Crystallographica Section C (2004) 60, 8 o611-o613
a=7.981(3)Å b=11.388(3)Å c=12.497(3)Å
α=117.065(3)° β=100.394(10)° γ=94.856(3)°
5,<i>syn</i>-7-Bis(trimethylsilyl)-5-norbornene-<i>endo</i>-2,3-dicarboxylic acid
C15H26O4Si2
Acta Crystallographica Section C (2008) 64, 8 o423-o425
a=16.9370(4)Å b=6.8184(16)Å c=16.5770(4)Å
α=90° β=97.667(4)° γ=90°
3-{[6-(4-Chlorophenyl)imidazo[2,1-<i>b</i>][1,3,4]thiadiazol-2-yl]methyl}- 1,2-benzoxazole
C18H11ClN4OS
Acta Crystallographica Section E (2011) 67, 3 o617-o618
a=38.419(7)Å b=5.7761(10)Å c=14.772(3)Å
α=90.00° β=108.004(5)° γ=90.00°
2-Amino-6-methyl-4,5,6,7-tetrahydro-1-benzothiophene-3-carbonitrile
C10H12N2S
Acta Crystallographica Section E (2011) 67, 3 o699
a=9.0415(2)Å b=8.3294(2)Å c=13.1283(3)Å
α=90.00° β=90.169(2)° γ=90.00°
2-Amino-7-oxo-4,5,6,7-tetrahydro-1-benzothiophene-3-carbonitrile
C9H8N2OS
Acta Crystallographica Section E (2010) 66, 10 o2616-o2617
a=7.2986(3)Å b=8.7555(3)Å c=14.7307(6)Å
α=90° β=94.1510(10)° γ=90°
3-{[5-(4-Bromophenyl)imidazo[2,1-<i>b</i>][1,3,4]thiadiazol-2-yl]methyl}- 1,2-benzoxazole
C18H11BrN4OS
Acta Crystallographica Section E (2011) 67, 1 o154
a=38.985(17)Å b=5.764(3)Å c=14.925(6)Å
α=90.00° β=109.191(13)° γ=90.00°
2-(4-Methylsulfanylphenyl)-1<i>H</i>-benzimidazol-3-ium bromide
C14H13N2S,Br
Acta Crystallographica Section E (2011) 67, 2 o341-o342
a=5.3289(2)Å b=24.0195(12)Å c=10.9544(5)Å
α=90° β=100.113(2)° γ=90°
6-(4-Bromophenyl)-2-(4-fluorobenzyl)imidazo[2,1-<i>b</i>][1,3,4]thiadiazole
C17H11BrFN3S
Acta Crystallographica Section E (2011) 67, 4 o779
a=10.505(4)Å b=5.617(2)Å c=25.877(11)Å
α=90.00° β=91.566(7)° γ=90.00°
2-Phenyl-8,9,10,11-tetrahydro-1- benzothieno[3,2-<i>e</i>][1,2,4]triazolo[1,5-<i>c</i>]pyrimidine
C17H14N4S
Acta Crystallographica Section E (2011) 67, 4 o777-o778
a=8.6239(16)Å b=20.512(4)Å c=8.5952(16)Å
α=90.00° β=111.975(3)° γ=90.00°
Bis{2-[4-(methylsulfanyl)phenyl]-1<i>H</i>-benzimidazol-3-ium} tetrabromidocuprate(II) dihydrate
2(C14H13N2S),Br4Cu2,2(H2O)
Acta Crystallographica Section E (2011) 67, 5 m578
a=7.6878(5)Å b=11.8358(7)Å c=18.5485(9)Å
α=85.305(4)° β=84.778(5)° γ=80.692(5)°
Bis{2-[4-(methylsulfanyl)phenyl]-1<i>H</i>-benzimidazol-3-ium} tetrabromidocadmate(II) ethanol monosolvate
2(C14H13N2S),Br4Cd2,C2H6O
Acta Crystallographica Section E (2011) 67, 6 m771
a=22.1321(15)Å b=13.8746(10)Å c=22.2594(16)Å
α=90.00° β=90.00° γ=90.00°
7-Methyl-5,6,7,8-tetrahydro-1-benzothieno[2,3-<i>d</i>]pyrimidin-4-amine
C11H13N3S
Acta Crystallographica Section E (2011) 67, 7 o1636-o1637
a=10.395(4)Å b=8.422(3)Å c=13.155(5)Å
α=90.00° β=110.015(6)° γ=90.00°
2-Amino-4-methyl-4,5,6,7-tetrahydro-1-benzothiophene-3-carbonitrile
C10H12N2S
Acta Crystallographica Section E (2012) 68, 10 o3025
a=9.6771(2)Å b=7.6364(2)Å c=13.8156(3)Å
α=90.00° β=100.221(2)° γ=90.00°
Ethyl 3-ethoxycarbonylmethyl-7-methyl-5-phenyl-5<i>H</i>- thiazolo[3,2-<i>a</i>]pyrimidine-6-carboxylate
C20H22N2O4S
Acta Crystallographica Section E (2012) 68, 10 o2878
a=10.0861(4)Å b=7.7954(3)Å c=23.4088(10)Å
α=90.00° β=95.000(3)° γ=90.00°
1-(2-Chloroethyl)-1<i>H</i>-pyrazolo[3,4-<i>d</i>]pyrimidin-4(5<i>H</i>)-one
C7H7ClN4O
Acta Crystallographica Section E (2012) 68, 7 o2083
a=4.64480(10)Å b=8.07920(10)Å c=22.7335(4)Å
α=90.00° β=93.5540(10)° γ=90.00°
Methyl 5-(4-hydroxy-3-methoxyphenyl)-2-(4-methoxybenzylidene)-7-methyl-3-oxo- 2,3-dihydro-5<i>H</i>-thiazolo[3,2-<i>a</i>]pyrimidine-6-carboxylate
C24H22N2O6S
Acta Crystallographica Section E (2011) 67, 12 o3444
a=6.8096(12)Å b=9.9343(18)Å c=16.246(3)Å
α=86.816(3)° β=85.588(3)° γ=81.318(3)°
Methyl 2-(2-bromobenzylidene)-5-(4-hydroxyphenyl)-7-methyl-3-oxo-2,3-dihydro- 5<i>H</i>-1,3-thiazolo[3,2-<i>a</i>]pyrimidine-6-carboxylate
C22H17BrN2O4S
Acta Crystallographica Section E (2012) 68, 4 o1257-o1258
a=9.851(2)Å b=23.461(6)Å c=9.416(2)Å
α=90.00° β=111.229(5)° γ=90.00°
Ethyl 3-acetyl-4-(3-methoxyphenyl)-6-methyl-2-sulfanylidene-1,2,3,4- tetrahydropyrimidine-5-carboxylate
C17H20N2O4S
Acta Crystallographica Section E (2012) 68, 5 o1555
a=11.515(2)Å b=7.3687(16)Å c=20.049(4)Å
α=90.00° β=90.960(4)° γ=90.00°
4-Imino-2,7-dimethyl-5,6,7,8-tetrahydro-4<i>H</i>- 1-benzothieno[2,3-<i>d</i>]pyrimidin-3-amine
C12H16N4S
Acta Crystallographica Section E (2012) 68, 8 o2468
a=6.7514(5)Å b=8.7139(6)Å c=11.8309(9)Å
α=97.221(4)° β=102.820(4)° γ=112.482(3)°